Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by products • Market overview • Global infection control products market • Global biosafety products market PART 07: Geographical segmentation • Market overview • Infection control and biosafety products market in Americas • Infection control and biosafety products market in EMEA • Infection control and biosafety products market in APAC PART 08: Market segmentation by end-user • Market overview • Global infection control and biosafety products by healthcare and research laboratories • Global infection control and biosafety products market by domestic and commercial users PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Increased awareness of sanitation and hygiene • Growing number of end-users • Increased availability of products • Growth of emerging markets • Rise in older population PART 12: Vendor landscape • Competitive landscape PART 13: Key vendor analysis • 3M • Reckitt Benckiser • BODE Chemie • STERIS • Thermo Fisher Scientific • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits Exhibit 01: Overview of global infection control and biosafety products market from stakeholder's perspective Exhibit 02: Key factors impacting growth of global infection control and biosafety products market Exhibit 03: Global infection control and biosafety products market segmentation by products Exhibit 04: Segmentation of infection control products Exhibit 05: Classification of disinfectants based on their level of impact Exhibit 06: Segmentation of biosafety products Exhibit 07: Global infection control and biosafety products market 2016-2021 ($ billions) Exhibit 08: Five forces analysis Exhibit 09: Global infection control and biosafety products market by product type 2016-2021 Exhibit 10: Global infection control products market 2016-2021 ($ billions) Exhibit 11: Global biosafety products market 2016-2021 ($ billions) Exhibit 12: Global infection control and biosafety products market by geography Exhibit 13: Global infection control and biosafety products market by geography 2016-2021 (% share) Exhibit 14: Infection control and biosafety products market in Americas 2016-2021 ($ billions) Exhibit 15: Infection control and biosafety products market in EMEA 2016-2021 ($ billions) Exhibit 16: Aging population growth in major countries in EMEA (% of population) Exhibit 17: Infection control and biosafety products market in APAC 2016-2021 ($ billions) Exhibit 18: Global infection control and biosafety products market by end-users 2016-2021 (% share) Exhibit 19: Sources of acquired infection by hospitals and research laboratories Exhibit 20: Global infection control and biosafety products market by healthcare and research laboratories 2016-2021 ($ billions) Exhibit 21: Sources of acquired infection by domestic and commercial users Exhibit 22: Global infection control and biosafety products market by domestic and commercial users 2016-2021 ($ billions) Exhibit 23: Average annual per capita growth rate (AAGR) in healthcare spending vs. GDP of countries 2009-2013 (%) Exhibit 24: Percentage of rural and urban population using sanitation facilities in different geographic locations 2015 Exhibit 25: Growth opportunities of different research areas in life science and related research Exhibit 26:M: Profile Exhibit 27:M: Strength analysis Exhibit 28:M: Strategy assessment Exhibit 29:M: Opportunity assessment Exhibit 30: Reckitt Benckiser: Profile Exhibit 31: Reckitt Benckiser: Strength analysis Exhibit 32: Reckitt Benckiser: Strategy assessment Exhibit 33: Reckitt Benckiser: Opportunity assessment Exhibit 34: BODE Chemie: Profile Exhibit 35: BODE Chemie: Strength analysis Exhibit 36: BODE Chemie: Strategy assessment Exhibit 37: BODE Chemie: Opportunity assessment Exhibit 38: STERIS: Profile Exhibit 39: STERIS: Strength analysis Exhibit 40: STERIS: Strategy assessment Exhibit 41: STERIS: Opportunity assessment Exhibit 42: Thermo Fisher Scientific: Profile Exhibit 43: Thermo Fisher Scientific: Strength analysis Exhibit 44: Thermo Fisher Scientific: Strategy assessment Exhibit 45: Thermo Fisher Scientific: Opportunity assessment

3M, Reckitt Benckiser, BODE Chemie, STERIS, Thermo Fisher Scientific, ABC Compounding, American Biotech Labs, Baxter, Bio-Cide International, CareFusion (BD), Ecolab, HEMCO Corporation, Kewaunee, Labconco, Metrex Research, The Baker Company, The Clorox Company, and Terra Universal.